search
Back to results

Minimally Invasive Closure of Umbilical Hernias (MIC)

Primary Purpose

Umbilical Hernia

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Deflux
Sponsored by
South Shore Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Umbilical Hernia focused on measuring Minimally invasive surgery, Umbilical hernia, Infant

Eligibility Criteria

1 Year - 5 Years (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age 1-5 years
  • Umbilical hernia>1cm. diameter.
  • Undergoing either a general surgical or urologic procedure under general anesthesia other than umbilical hernia repair.
  • No previous umbilical hernia repair.

Exclusion Criteria:

  • Over 5 years
  • No umbilical hernia
  • No other surgery required
  • Previous umbilical hernia repair

Sites / Locations

  • Children's Hospital Boston and South Shore Hospital

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Deflux

Arm Description

Treatment with Deflux.

Outcomes

Primary Outcome Measures

Close Belly Button or Umbilical Hernia
The study was terminated prematurely by the IRB. Results are not shared due to data integrity concerns. These concerns are outlined in an FDA warning letter.

Secondary Outcome Measures

Full Information

First Posted
June 25, 2008
Last Updated
October 4, 2017
Sponsor
South Shore Hospital
Collaborators
Q-Med Scandinavia, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT00706329
Brief Title
Minimally Invasive Closure of Umbilical Hernias
Acronym
MIC
Official Title
Study of Minimally Invasive Closure of Umbilical Hernias
Study Type
Interventional

2. Study Status

Record Verification Date
October 2017
Overall Recruitment Status
Terminated
Why Stopped
The study was terminated prematurely by the IRB due to data integrity and protocol compliance issues
Study Start Date
April 2008 (undefined)
Primary Completion Date
March 2009 (Actual)
Study Completion Date
March 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
South Shore Hospital
Collaborators
Q-Med Scandinavia, Inc.

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to test the use of "Deflux" injections in a minimally invasive closure of umbilical (belly button) hernias in infants between birth and five years. The study is designed to demonstrate that the use of this device can safely and effectively close an umbilical hernia.
Detailed Description
All patients will undergo general anesthesia for their primary procedure, i.e. inguinal hernia repair. Once under general anesthesia, the abdomen will be prepped and draped in the usual sterile surgical fashion. The edge of the umbilical hernia defect will be palpated and in case there are any contents of the hernia present, they will be pushed into the abdominal cavity. Adequate relaxation, again, will be assured. A 24 gauge needle will be used to inject 1cc of Deflux ("Study Product") into each quadrant at the junction between the preperitoneal space and the inner palpable rim of the fascial defect. The surgeon's index finger stays in the center of the hernia defect, protecting the hernia sac contents from re-herniating. Closure of the umbilical defect will be confirmed by palpation immediately after injection. A sterile wound dressing will be applied and the primary surgical procedure will be performed afterwards. Definition of Primary and Secondary Outcomes/Endpoints: The endpoint of this study is closure of the umbilical hernia. Data Collection Methods, Assessments, and Schedule (what assessments performed, how often): A data collection file is started at the time of enrollment in the study. Data collection includes patient age, gender, and weight at the time of operation, inner diameter of the umbilical hernia defect at the time of operation, description of the immediate postoperative results and follow-up exams at two weeks, one month, and six months.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Umbilical Hernia
Keywords
Minimally invasive surgery, Umbilical hernia, Infant

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
25 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Deflux
Arm Type
Experimental
Arm Description
Treatment with Deflux.
Intervention Type
Device
Intervention Name(s)
Deflux
Intervention Description
Patients undergo surgery using Deflux to correct umbilical hernia
Primary Outcome Measure Information:
Title
Close Belly Button or Umbilical Hernia
Description
The study was terminated prematurely by the IRB. Results are not shared due to data integrity concerns. These concerns are outlined in an FDA warning letter.
Time Frame
After surgery, subjects will be followed at intervals of one month and six months from date of surgery.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Year
Maximum Age & Unit of Time
5 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age 1-5 years Umbilical hernia>1cm. diameter. Undergoing either a general surgical or urologic procedure under general anesthesia other than umbilical hernia repair. No previous umbilical hernia repair. Exclusion Criteria: Over 5 years No umbilical hernia No other surgery required Previous umbilical hernia repair
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Neil R. Feins, M.D.
Organizational Affiliation
Children's Hospital Boston and South Shore Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Children's Hospital Boston and South Shore Hospital
City
South Weymouth
State/Province
Massachusetts
ZIP/Postal Code
02190
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Minimally Invasive Closure of Umbilical Hernias

We'll reach out to this number within 24 hrs